Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00819793 · ClinicalTrials.gov registry record · NA

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

A NA study, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT00819793: Completed NA study, sponsored by Abbott Medical Devices.

NCT00819793 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00819793, a NA study, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.

Primary Outcome

Number of patients alive 30 days after device implantation

Interventions

  • DEVICE CentriMag Ventricular Assist System

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2008-10
Est. Completion 2013-09
Phase NA
Abbott Medical Devices

261 total trials

What the finished NCT00819793 record still lists

NCT00819793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which CentriMag Ventricular Assist System is the first listed.

NCT00819793 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00819793 about?

NCT00819793 is a clinical study titled "CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass". The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.

What is the current status of trial NCT00819793?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2008-10. Estimated completion is 2013-09.

What interventions are being tested in trial NCT00819793?

The interventions under investigation include: CentriMag Ventricular Assist System (DEVICE).

Who is sponsoring clinical trial NCT00819793?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00819793's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00819793, the US trial registry maintained by the National Library of Medicine. NCT00819793 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.